Chundsell Medicals ^Private

Chundsell Medicals is a molecular diagnostics organization that specializes in cancer research. Founded in 2007 as a spin-off from Karolinska Institutet, their main goal is to commercialize the research results of Chunde Li and his group on prostate cancer genomics. Their flagship product, the Prostatype® Test System, assesses prostate cancer aggressiveness by measuring the expression pattern of three specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. This information, combined with selected clinical parameters, helps healthcare professionals predict disease outcome, overall survival, and cancer-specific survival for patients.